GenomOncology is a precision medicine software company that focuses on enhancing cancer care through data-driven insights. Their core offering, the Precision Oncology Platform (POP), serves as a comprehensive foundation for their suite of clinical informatics solutions. This platform utilizes advanced algorithms and machine learning techniques to transform complex data into actionable insights, thereby streamlining precision oncology workflows. GenomOncology's solutions are designed to be highly adaptable, allowing seamless integration into existing healthcare processes, which ultimately improves operational efficiency and supports informed decision-making in cancer treatment.

The company also offers a range of specialized tools and services, including data enablement solutions that convert unstructured data into valuable assets, and a pathology solution that facilitates the processing and reporting of genetic test results. Their decision support systems combine clinical guidelines and computational algorithms to provide healthcare professionals with actionable recommendations for cancer diagnosis and management. Additionally, GenomOncology's insights and analytics tools enable deeper exploration of patient data, while their curation services ensure that users have access to the latest information on therapies, clinical trials, and relevant annotations, thereby enhancing the overall quality of cancer care.

United States

GenomOncology enables real-time clinical decision-making at the point-of-care for Molecular Pathologists, Clinical Oncologists and Cancer Informaticists in their research of cancer treatments and therapies for cancer patients.

GenomOncology

Company Details